
GRI Bio, Inc.
GRIHealthcare|Biotechnology|US
$1.88
+0.33 (+21.29%)
DCF Value
$65.34
Tangible Book / Share
$5.70
Cash / Share
$6.06
Ownership Breakdown
100.0%
Float
2.2M
Shares Outstanding
2.2M
Float Shares
Major Holders (3)
Combined: 15.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
Insider Trades (25)
Last 4 quarters: 458,976 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kelly Leanne | Chief Financial Officer | Sep 18, 2025 | AWARD | 43,222 | $1.93 | $83.4K | Form 4 |
| Szekeres David Leslie | director | Sep 18, 2025 | AWARD | 39,897 | $1.93 | $77.0K | Form 4 |
| Baker David Charles | director | Sep 18, 2025 | AWARD | 23,605 | $1.93 | $45.6K | Form 4 |
| SIMPSON CAMILLA V | director | Sep 18, 2025 | AWARD | 23,605 | $1.93 | $45.6K | Form 4 |
| Chaturvedi Vipin | Chief Scientific Officer | Sep 18, 2025 | AWARD | 43,222 | $1.93 | $83.4K | Form 4 |
| Rongen Roelof | director | Sep 18, 2025 | AWARD | 23,605 | $1.93 | $45.6K | Form 4 |
| Hertz Walter Marc | director, officer: Chief Executive Officer | Sep 18, 2025 | AWARD | 103,067 | $1.93 | $198.9K | Form 4 |
| Hertz Walter Marc | director, officer: Chief Executive Officer | Aug 26, 2025 | AWARD | 26,688 | $1.41 | $37.6K | Form 4 |
| Szekeres David Leslie | director | Aug 26, 2025 | AWARD | 10,276 | $1.41 | $14.5K | Form 4 |
| Baker David Charles | director | Aug 26, 2025 | AWARD | 5,994 | $1.41 | $8.5K | Form 4 |
| Rongen Roelof | director | Aug 26, 2025 | AWARD | 5,994 | $1.41 | $8.5K | Form 4 |
| Chaturvedi Vipin | Chief Scientific Officer | Aug 26, 2025 | AWARD | 11,854 | $1.41 | $16.7K | Form 4 |
| SIMPSON CAMILLA V | director | Aug 26, 2025 | AWARD | 5,994 | $1.41 | $8.5K | Form 4 |
| Kelly Leanne | Chief Financial Officer | Aug 26, 2025 | AWARD | 11,854 | $1.41 | $16.7K | Form 4 |
| SIMPSON CAMILLA V | director | Aug 13, 2025 | AWARD | 4,527 | $1.30 | $5.9K | Form 4 |
| Baker David Charles | director | Aug 13, 2025 | AWARD | 4,527 | $1.30 | $5.9K | Form 4 |
| Rongen Roelof | director | Aug 13, 2025 | AWARD | 4,527 | $1.30 | $5.9K | Form 4 |
| Szekeres David Leslie | director | Aug 13, 2025 | AWARD | 7,545 | $1.30 | $9.8K | Form 4 |
| Kelly Leanne | Chief Financial Officer | Jan 23, 2025 | AWARD | 43,319 | $0.69 | $29.7K | Form 4 |
| Chaturvedi Vipin | Chief Scientific Officer | Jan 23, 2025 | AWARD | 43,319 | $0.69 | $29.7K | Form 4 |
| Hertz Walter Marc | director, officer: Chief Executive Officer | Jan 23, 2025 | AWARD | 129,730 | $0.69 | $89.0K | Form 4 |
| SIMPSON CAMILLA V | director | Jan 23, 2025 | AWARD | 30,297 | $0.69 | $20.8K | Form 4 |
| Baker David Charles | director | Jan 23, 2025 | AWARD | 30,297 | $0.69 | $20.8K | Form 4 |
| Szekeres David Leslie | director | Jan 23, 2025 | AWARD | 51,937 | $0.69 | $35.6K | Form 4 |
| Rongen Roelof | director | Jan 23, 2025 | AWARD | 30,297 | $0.69 | $20.8K | Form 4 |